Skip to main content

Febbo Phillip G.'s Form 4 filing

Veracyte, Inc. (VCYT) · filed Sep 4, 2026

Accession no.
0001649245-26-000009
Filed
Sep 4, 2026, 7:54 PM ET
Trade date
Sep 2-4, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions. Open-market sales total $564.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Febbo Phillip G.CIK 0001649245Officer (Chief Scientific & Med Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 2, 2026Common StockFTax withholdingDisposed−3,639$44.88−$163,318.32146,158Direct
Sep 4, 2026Common StockSSaleDisposed−10,405$42.89F3−$446,304.79135,753Direct
Sep 4, 2026Common StockSSaleDisposed−2,705$43.66F4−$118,105.17133,048Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F3

Represents weighted average sales price. Sale prices for the transactions range from $42.47 to $43.47. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Referenced by the price of 1 transaction in Table I.

F4

Represents weighted average sales price. Sale prices for the transactions range from $43.475 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)